New research shows that eosinophils, immune cells usually linked to allergies, also play a protective role against Candida ...
Clinical remission rates were over 85% for both TREMFYA® maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies TREMFYA® is the only ...